E-Newsletter - September 2022
Upcoming Group Meeting


ALLIANCE fall hybrid GROUP MEETING CONVENES november 2-5

The Alliance for Clinical Trials in Oncology will convene its 2022 Fall Hybrid Group Meeting in Chicago November 2-5. This will be the second hybrid meeting where members and guests can attend either in-person or virtually. Scientists, clinical research professionals, patient advocates and others interested in the latest developments in cancer research are expected to participate in the four-day meeting held at the Loews Chicago O'Hare Hotel. Meeting attendees will select from nearly 100 disease, modality, administrative and special sessions to attend led by distinguished oncology researchers and clinical trial specialists from across the country. This meeting will showcase novel and innovative cancer control, prevention, and treatment trials that are conducted by investigators through a multidisciplinary academic and community research network, which is part of the NCI National Clinical Trials Network (NCTN) and Community Oncology Research Program (NCORP).


Remember: sessions listed as closed are only open to official committee members and invited guests.
Registration must be completed to gain access to the Zoom information in the meeting app.

For questions about the Group meeting, contact AllianceTravel@bwh.harvard.edu.



Read more articles in this month's e-newsletter: